Lisandro J. Falomir-Lockhart
Max Planck Society
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lisandro J. Falomir-Lockhart.
Journal of Biological Chemistry | 2011
Volodymyr V. Shvadchak; Lisandro J. Falomir-Lockhart; Dmytro A. Yushchenko; Thomas M. Jovin
Parkinson disease is characterized cytopathologically by the deposition in the midbrain of aggregates composed primarily of the presynaptic neuronal protein α-synuclein (AS). Neurotoxicity is currently attributed to oligomeric microaggregates subjected to oxidative modification and promoting mitochondrial and proteasomal dysfunction. Unphysiological binding to membranes of these and other organelles is presumably involved. In this study, we performed a systematic determination of the influence of charge, phase, curvature, defects, and lipid unsaturation on AS binding to model membranes using a new sensitive solvatochromic fluorescent probe. The interaction of AS with vesicular membranes is fast and reversible. The protein dissociates from neutral membranes upon thermal transition to the liquid disordered phase and transfers to vesicles with higher affinity. The binding of AS to neutral and negatively charged membranes occurs by apparently different mechanisms. Interaction with neutral bilayers requires the presence of membrane defects; binding increases with membrane curvature and rigidity and decreases in the presence of cholesterol. The association with negatively charged membranes is much stronger and much less sensitive to membrane curvature, phase, and cholesterol content. The presence of unsaturated lipids increases binding in all cases. These findings provide insight into the relation between membrane physical properties and AS binding affinity and dynamics that presumably define protein localization in vivo and, thereby, the role of AS in the physiopathology of Parkinson disease.
PLOS ONE | 2014
Adrian Flierl; Luís M. A. Oliveira; Lisandro J. Falomir-Lockhart; Sally K. Mak; Jayne Hesley; Frank Soldner; Donna J. Arndt-Jovin; Rudolf Jaenisch; J. William Langston; Thomas M. Jovin; Birgitt Schüle
Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Genetic predisposition, such as point mutations and copy number variants of the SNCA gene locus can cause very similar PD-like neurodegeneration. The impact of altered α-synuclein protein expression on integrity and developmental potential of neuronal stem cells is largely unexplored, but may have wide ranging implications for PD manifestation and disease progression. Here, we investigated if induced pluripotent stem cell-derived neuronal precursor cells (NPCs) from a patient with Parkinson’s disease carrying a genomic triplication of the SNCA gene (SNCA-Tri). Our goal was to determine if these cells these neuronal precursor cells already display pathological changes and impaired cellular function that would likely predispose them when differentiated to neurodegeneration. To achieve this aim, we assessed viability and cellular physiology in human SNCA-Tri NPCs both under normal and environmentally stressed conditions to model in vitro gene-environment interactions which may play a role in the initiation and progression of PD. Human SNCA-Tri NPCs displayed overall normal cellular and mitochondrial morphology, but showed substantial changes in growth, viability, cellular energy metabolism and stress resistance especially when challenged by starvation or toxicant challenge. Knockdown of α-synuclein in the SNCA-Tri NPCs by stably expressed short hairpin RNA (shRNA) resulted in reversal of the observed phenotypic changes. These data show for the first time that genetic alterations such as the SNCA gene triplication set the stage for decreased developmental fitness, accelerated aging, and increased neuronal cell loss. The observation of this “stem cell pathology” could have a great impact on both quality and quantity of neuronal networks and could provide a powerful new tool for development of neuroprotective strategies for PD.
Cell Death and Disease | 2015
Luís M. A. Oliveira; Lisandro J. Falomir-Lockhart; Michelle G. Botelho; K-H Lin; Pauline Wales; Jan C. Koch; Ellen Gerhardt; Holger Taschenberger; Tiago F. Outeiro; Paul Lingor; Birgitt Schüle; Donna J. Arndt-Jovin; Thomas M. Jovin
We have assessed the impact of α-synuclein overexpression on the differentiation potential and phenotypic signatures of two neural-committed induced pluripotent stem cell lines derived from a Parkinsons disease patient with a triplication of the human SNCA genomic locus. In parallel, comparative studies were performed on two control lines derived from healthy individuals and lines generated from the patient iPS-derived neuroprogenitor lines infected with a lentivirus incorporating a small hairpin RNA to knock down the SNCA mRNA. The SNCA triplication lines exhibited a reduced capacity to differentiate into dopaminergic or GABAergic neurons and decreased neurite outgrowth and lower neuronal activity compared with control cultures. This delayed maturation phenotype was confirmed by gene expression profiling, which revealed a significant reduction in mRNA for genes implicated in neuronal differentiation such as delta-like homolog 1 (DLK1), gamma-aminobutyric acid type B receptor subunit 2 (GABABR2), nuclear receptor related 1 protein (NURR1), G-protein-regulated inward-rectifier potassium channel 2 (GIRK-2) and tyrosine hydroxylase (TH). The differentiated patient cells also demonstrated increased autophagic flux when stressed with chloroquine. We conclude that a two-fold overexpression of α-synuclein caused by a triplication of the SNCA gene is sufficient to impair the differentiation of neuronal progenitor cells, a finding with implications for adult neurogenesis and Parkinson’s disease progression, particularly in the context of bioenergetic dysfunction.
Journal of Biological Chemistry | 2006
Lisandro J. Falomir-Lockhart; Lisandro Laborde; Peter C. Kahn; Judith Storch; Betina Córsico
Fatty acid transfer from intestinal fatty acid-binding protein (IFABP) to phospholipid membranes occurs during protein-membrane collisions. Electrostatic interactions involving the α-helical “portal” region of the protein have been shown to be of great importance. In the present study, the role of specific lysine residues in the α-helical region of IFABP was directly examined. A series of point mutants in rat IFABP was engineered in which the lysine positive charges in this domain were eliminated or reversed. Using a fluorescence resonance energy transfer assay, we analyzed the rates and mechanism of fatty acid transfer from wild type and mutant proteins to acceptor membranes. Most of the α-helical domain mutants showed slower absolute fatty acid transfer rates to zwitterionic membranes, with substitution of one of the lysines of the α2 helix, Lys27, resulting in a particularly dramatic decrease in the fatty acid transfer rate. Sensitivity to negatively charged phospholipid membranes was also reduced, with charge reversal mutants in the α2 helix the most affected. The results support the hypothesis that the portal region undergoes a conformational change during protein-membrane interaction, which leads to release of the bound fatty acid to the membrane and that the α2 segment is of particular importance in the establishment of charge-charge interactions between IFABP and membranes. Cross-linking experiments with a phospholipid-photoactivable reagent underscored the importance of charge-charge interactions, showing that the physical interaction between wild-type intestinal fatty acid-binding protein and phospholipid membranes is enhanced by electrostatic interactions. Protein-membrane interactions were also found to be enhanced by the presence of ligand, suggesting different collisional complex structures for holo- and apo-IFABP.
Clinical Lipidology | 2009
Betina Córsico; Lisandro J. Falomir-Lockhart
Abstract Evaluation of: Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS: Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134, 933–944 (2008). Alterations in lipid metabolism are linked to metabolic diseases such as obesity, diabetes, fatty liver and atherosclerosis, although the details of the underlying specific mechanisms of this connection are not well understood. In this work, mice deficient in adipose tissue fatty acid-binding proteins (FABP)4 and 5, were employed to explore the mechanisms connecting local alterations in adipose tissue lipid metabolism to systemic metabolic outcomes. FABPs are lipid chaperones that are postulated to target intracellular lipids to different organelles and metabolic pathways inside the cell. Several FABPs have been reported to play a role in systemic metabolic regulation, especially those from adipose tissue. Hence, animals lacking FABPs are powerful models to explore lipid metabolism and signaling inside the cell and between organs. Employing quantitative lipidomic ana lysis, physiological and molecular approaches in FABP-deficient mice, in this work, a specific fatty acid is identified as a lipid hormone, linking adipose tissue to systemic metabolism.
Archive | 2013
Lisandro J. Falomir-Lockhart; Betina Córsico; Gisela Raquel Franchini; Eduardo De Gerónimo; Luciana Rodriguez-Sawicki; Natalia Botasso
Acta Bioquimica Clinica Latinoamericana | 2013
Lisandro J. Falomir-Lockhart; Betina Córsico; Gisela Raquel Franchini; Eduardo De Gerónimo; Luciana Rodriguez-Sawicki; Natalia Botasso
Biophysical Journal | 2012
Lisandro J. Falomir-Lockhart; Claudio D. Borsarelli; Veronika Ostatná; Jonathan A. Fauerbach; Emil Paleček; Elizabeth A. Jares-Erijman; Thomas M. Jovin
Biophysical Journal | 2012
Volodymyr V. Shvadchak; Lisandro J. Falomir-Lockhart; Dmytro A. Yushchenko; Yves Mély; Thomas M. Jovin
Archive | 2011
Volodymyr V. Shvadchak; Lisandro J. Falomir-Lockhart; Dmytro A. Yushchenko; Thomas M. Jovin